Autor: |
Cristina Calvo, Alfredo Tagarro, Ana Méndez Echevarría, Belén Fernández Colomer, M. Rosa Albañil Ballesteros, Quique Bassat, M. José Mellado Peña |
Jazyk: |
Spanish; Castilian |
Rok vydání: |
2021 |
Předmět: |
|
Zdroj: |
Anales de Pediatría (English Edition), Vol 95, Iss 5, Pp 382.e1-382.e8 (2021) |
Druh dokumentu: |
article |
ISSN: |
2341-2879 |
DOI: |
10.1016/j.anpede.2021.10.002 |
Popis: |
Since the COVID-19 pandemic was declared in March 2020, we have learned a lot about the SARS-CoV-2 coronavirus, and its role in pediatric pathology.Children are infected in a rate quite similar to adults, although in most cases they suffer mild or asymptomatic symptoms. Around 1% of those infected require hospitalization, less than 0.02% require intensive care, and mortality is very low and generally in children with comorbidities. The most common clinical diagnoses are upper or lower respiratory infections, gastrointestinal infection and, more seriously, multisystemic inflammatory syndrome (MIS-C). Most episodes do not require treatment, except for MIS-C. Remdesivir has been widely used as a compassionate treatment and its role has yet to be defined.The newborn can become infected, although vertical transmission is very low ( |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|